Connect with us

Hi, what are you looking for?

News

NAFDAC Endorses Pfizer-BionTech Vaccines for Use in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved Pfizer-BionTech vaccines for possible use in Nigeria.

Prof Mojisola Adeyeye, Director-General, NAFDAC, disclosed this on Friday at a news conference in Lagos, Southwest Nigeria.

Adeyeye said the vaccines were reviewed carefully by the NAFDAC staff COVID-19 vaccine committee to make sure that the science behind the development was well understood and in accord with world regulatory activities.

She said NAFDAC used different mechanisms to approve the vaccine.

According to her, the body used reliance, “meaning that a more mature regulatory agency across the globe, we can use that as a basis for our review.”

She said NAFDAC would get the assessment report, know the peculiarity there, then the COVID-19 committee would get to do their job.

NAFDAC had earlier in the year approved the use of AstraZeneca vaccines in Nigeria, which was distributed to states.

The first dose of AstraZeneca vaccines have been administered in Nigeria while administration of the second dose would kick-off in May 2020.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

ad

You May Also Like

Tech

Samsung Electronics has taken a bold step in enhancing user experience and inclusivity by introducing Hausa, Igbo, and Yoruba as official language options on...

News

In a move poised to revolutionize Nigeria’s poultry industry, agritech company Afrimash has launched a USSD solution that enables farmers to verify the authenticity...

News

As the application window for the fourth edition of the MTN’s coveted Media Innovation Programme (MIP) remains open till April 7, 2025, prospective fellows...

News

In a bold step toward addressing Nigeria’s persistent energy challenges, TD Africa has partnered with EcoFlow, a global energy leader, to introduce an innovative...